arrow
E

Elna Osso

Harvard University
H指数:8
被引数:319

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis

药物敏感结核病患者HIRIF试验中肝毒性的药代动力学和药物基因组学预测因子

2026-03-060
OA
Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial

HIRIF试验中药物基因组学对一线抗结核药物药代动力学的影响

2025-04-170
PRE
Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan
2024-06-041
OAAI
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs
2023-08-224
OAAI
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
2022-03-0425
OAAI
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
2022-01-1339
OAAI
Setting up pharmacovigilance based on available endTB Project data for bedaquiline
2020-10-0113
OAAI